Contact PR

To use this feature, join Babbler easily !

arrow_back

Babbler allows PR people and reporters to collaborate a better way.

By joining Babbler you will be able to access hundreds of newsrooms and PR contacts from your industrie(s) and also share with them your upcoming needs.

Their newsrooms are already on Babbler

You're 1 click away from signing up

Previous

Nice to see you again !

Press release

Media information: Sanofi Toujeo medical treatment
timer minutes reading time minute reading time

Copy link
switching-to-toujeo-r-in-a-real-world-setting-produced-a-similar-number-of-severe

Click to get original image size

SWITCHING TO TOUJEO® IN A REAL-WORLD SETTING PRODUCED A SIMILAR NUMBER OF SEVERE LOW BLOOD SUGAR EVENTS AS INSULIN DEGLUDEC

Adults with type 2 diabetes who switched their basal insulin therapy to Toujeo® or insulin degludec, experienced similar numbers of low blood sugar (hypoglycemia) events, according to the findings of two comparative real-world studies. Patients also experienced similar reduction of average blood sugar (HbA1c) with the different insulin treatments. 

  • Health & Medicine
  • Medicine
  • Men's Health
  • Women's Health
inscrit avec succès

Congratulations, you're registered on Babbler!

Discover now all the news waiting for you on Babbler: visit your newsfeed.!

Your topics have been selected, you can change it by clicking here

  • Health & Medicine
  • Medicine
  • Men's Health